Document is current
Any future updates will be listed below
-
Authors
Koumantou, Despoina
Barnea, Eilon
Martin-Esteban, Adrian
Maben, Zachary
Papakyriakou, Athanasios
Mpakali, Anastasia
Kokkala, Paraskevi
Pratsinis, Harris
Georgiadis, Dimitris
Stern, Lawrence J.
Admon, Arie
Stratikos, Efstratios https://orcid.org/0000-0002-3566-2309
-
Funding
Funding for this research was provided by:
Harry J. Lloyd Charitable Trust
National Institutes of Health (AI- 038996)
Ministry of Science and Technology, Israel (534165)
Ministry of Education and Religious Affairs, Sport and Culture (MIS 5002559)
- License Information
-
More Information
Article History
Received: 10 December 2018
Accepted: 11 June 2019
First Online: 20 June 2019
Compliance with ethical standards
:
: The authors declare they have no conflicts of interest.
: The work described in this paper was performed using commercially available cell lines. Therefore, no study approval was required, and no informed consent from the donors.
: The A375 human malignant melanoma cell line and the W6/32 hybridoma cell line (CRL-1619 and HB-95, respectively) were purchased from American Type Culture Collection (ATCC) and used as provided by the vendor without any further authentication. The Hi5 insect cell line was purchased from Thermo Fischer Scientific and used as provided by the vendor without any further authentication. HeLa-Kb cells were provided by Kenneth Rock (University of Massachusetts Medical School, Worcester, MA, USA) and have been described before []. The expression of the MHC-I allele Kb by the HeLa-Kb cell line was confirmed by FACS staining.
